MILAN GENGE, D.O.
Vision Therapy Optometrist in WILSON, North Carolina. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What stands out: MILAN GENGE, D.O. reported a CMS MIPS final score of 83.6986 out of 100, above the 83.1 national average, and filed 5,008 Medicare Part D claims in 2023. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.
MILAN GENGE, D.O. at a glance
Near national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in North Carolina
How Vision Therapy Optometrist compares to other specialties among North Carolina providers
Vision Therapy Optometrist share within North Carolina
Vision Therapy Optometrist is one of the more visible NUCC categories in North Carolina
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Medicare quality performance — MIPS
MILAN GENGE, D.O.'s 2023 MIPS final score plotted against the Vision Therapy Optometrist national average
- MIPS Final Score
- 83.6986/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Vision Therapy Optometrist) — 83.6986/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Vision Therapy Optometrist US NPIs
83.6986/100 MIPS final score — 0.6 pts above the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Vision Therapy Optometrist. Quality dim: 100. Cost dim: 45.662.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
MILAN GENGE, D.O. is a Vision Therapy Optometrist provider practicing in WILSON, North Carolina, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: D.O.. NPI: 1457313363. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.
MILAN GENGE, D.O. appears in the CMS NPPES registry as a Vision Therapy Optometrist provider holding D.O. credentials at 1707 MEDICAL PARK DR W, WILSON, NC, 27893, with a listed phone of (252) 291-7008. NPI 1457313363 was issued on 04/05/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what GENGE most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 5,008 prescription claims written by this provider, covering 1,054 Medicare beneficiaries and totaling roughly $518K in drug spend, split 38% brand-name and 62% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 83.6986/100 for the 2023 performance year (Quality 100, Cost 45.662), compared with the national average of 83.1.
Vision Therapy Optometrist is a narrow specialty nationwide, with 369 enrolled providers across 42 states and an average of 209 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1457313363 |
|---|---|
| Specialty | Vision Therapy Optometrist |
| Credentials | D.O. |
| Gender | Male |
| NPI Issued | 04/05/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm MILAN GENGE, D.O.'s current license status, disciplinary history, and board certifications with the North Carolina Medical Board in North Carolina before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Hospital and facility affiliations
Facilities where MILAN GENGE, D.O. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MILAN GENGE, D.O.. Source: openpaymentsdata.cms.gov.
Total received
$296
Largest payer
Alcon Vision LLC
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Above average
38% brand-name claims vs 62% generic, on 5,008 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 8,510
- Total Day Supply
- 244,007
- Brand vs Generic
- 38% brand / 62% generic
- Brand Drug Cost
- $414K
- Generic Drug Cost
- $104K
- Antibiotic Claims
- 12
Patient Demographics
- Average Patient Age
- 75.4 years
- Avg HCC Risk Score
- 1.37
- Gender Split
- 64% female / 36% male
- Age Distribution
- <65: 61, 65-74: 457, 75-84: 393, 85+: 143
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
| Drug | Claims |
|---|---|
| Latanoprost | 1,767 |
| Moxifloxacin Moxifloxacin Hcl | 489 |
| Timolol Maleate | 390 |
| Prednisolone Acetate | 376 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 342 |
| Brimonidine Tartrate | 304 |
| Dorzolamide Hcl | 278 |
| Lotemax Sm Loteprednol Etabonate | 209 |
| Prolensa Bromfenac Sodium | 203 |
| Combigan Brimonidine Tartrate/Timolol | 106 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Vision Therapy Optometrist Overview
How MILAN GENGE, D.O. fits within the Vision Therapy Optometrist landscape nationally.
MILAN GENGE, D.O.'s 5,008 claims are above the specialty average of 209.
Nearby Vision Therapy Optometrist Providers in North Carolina
Other clinicians with the same primary specialty enrolled in North Carolina, drawn from the same CMS NPPES roster as GENGE.
Compare Vision Therapy Optometrist nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore North Carolina
Frequently Asked Questions
What is MILAN GENGE, D.O.'s specialty? ▼
How much does MILAN GENGE, D.O. prescribe under Medicare Part D? ▼
What is MILAN GENGE, D.O.'s Medicare quality score? ▼
Where is MILAN GENGE, D.O. located? ▼
What is MILAN GENGE, D.O.'s NPI number? ▼
Does MILAN GENGE, D.O. prescribe more brand-name or generic drugs? ▼
How many Vision Therapy Optometrist providers are there in the US? ▼
What drugs does MILAN GENGE, D.O. prescribe most often? ▼
Does MILAN GENGE, D.O. accept Medicare? ▼
How can I verify MILAN GENGE, D.O.'s credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology